Hypomethylation of the MSLN promoter and transcriptional up-regulation have been suggested in MPM [11,12], pancreatic [13,14] and ovarian carcinoma [15,16], but few studies have reported post-transcriptional regulation of MSLN by miRNAs [17,18]. This evidence concerns the gene MSLN and ovarian carcinoma.